Thursday, 30 May 2019

How BioMarin May Revolutionize the Hemophilia Treatment Market - Yahoo Finance

How BioMarin May Revolutionize the Hemophilia Treatment Market  Yahoo Finance

The latest trial results for its hemophilia A gene therapy suggest it may eliminate or significantly reduce the need for weekly infusions.

No comments:

Post a Comment